While previous studies have examined PTEN loss and Ras activation primarily in the context of accelerating the growth of existing tumor lines, there remains a need to understand how the activation of these individual pathways could contribute to cancer progression beyond that of initial tumor growth. Here, PTEN is linked to cancer.